SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Recs

0
Player Avatar SmokeyJoeSmokin (88.25) Submitted: 12/11/2007 11:57:07 AM : Outperform Start Price: $2.52 SCLN Score: +137.79

These guys have some great drugs in their pipeline. This is a cheap biotech to buy for the long term.

Featured Broker Partners


Advertisement